Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs SHSSX overlap: 78% of top holdings shared

Bottom line

How much do XLV and SHSSX overlap?

78% of their top holdings overlap by weight. 17 securities appear in both funds' top 25, making up 73.8% of XLV's assets and 63.1% of SHSSX's. They are largely the same portfolio — owning both adds little diversification.

SHSSX holds far more positions (155 vs 65), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

XLVSHSSX
Weight overlap (top 25)78%
Shared holdings17
Weight in shared holdings73.8%63.1%
Total positions65155
Expense ratio0.08%0.86%
Holdings as ofJun 30, 2026May 29, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 29, 2026)

Holdings XLV and SHSSX have in common

Holding% of XLV% of SHSSXOverlap
Eli Lilly & Co16.51%12.29%12.29%
Johnson & Johnson10.64%8.77%8.77%
AbbVie Inc7.74%3.94%3.94%
UnitedHealth Group Inc6.57%6.10%6.10%
Merck & Co Inc5.52%4.94%4.94%
Amgen Inc3.40%3.37%3.37%
Thermo Fisher Scientific Inc3.24%3.02%3.02%
Abbott Laboratories2.75%1.97%1.97%
Gilead Sciences Inc2.73%4.19%2.73%
Intuitive Surgical Inc2.45%1.95%1.95%
Pfizer Inc2.39%2.61%2.39%
Vertex Pharmaceuticals Inc2.19%2.74%2.19%
Danaher Corp2.09%2.00%2.00%
Stryker Corp1.89%1.15%1.15%
Elevance Health Inc1.46%1.56%1.46%
Boston Scientific Corp1.10%1.59%1.10%
Regeneron Pharmaceuticals Inc1.08%0.91%0.91%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 29, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. CVS Health Corp — 2.30%
  2. Bristol-Myers Squibb Co — 2.05%
  3. Medtronic PLC — 1.75%
  4. McKesson Corp — 1.58%
  5. Cigna Group/The — 1.27%
  6. HCA Healthcare Inc — 1.05%
  7. Cardinal Health Inc — 0.97%
  8. Cencora Inc — 0.96%

Only in SHSSX

  1. Edwards Lifesciences Corp — 2.51%
  2. Teva Pharmaceutical Industries Ltd — 1.87%
  3. Argenx Se — 1.26%
  4. Biogen Inc — 1.21%
  5. Astrazeneca Plc — 1.21%
  6. Blackrock Funds III — 1.01%
  7. Revolution Medicines Inc — 0.96%
  8. Humana Inc — 0.92%

Asset mix

Asset typeXLVSHSSX
Stocks99.7%99.8%
Cash & short-term funds0.3%1.4%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 29, 2026)

Country mix

CountryXLVSHSSX
US97.9%93.9%
IE2.1%—
IL—1.9%
CH—1.4%
GB—1.4%
NL—1.3%
BM—0.3%
BE—0.3%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 29, 2026)

Check another pair

FAQ

How much do XLV and SHSSX overlap?
About 78% by weight. 17 securities appear in both funds' top 25 holdings; they make up 73.8% of XLV's assets and 63.1% of SHSSX's. They are largely the same portfolio — owning both adds little diversification.
What stocks do XLV and SHSSX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, UnitedHealth Group Inc, Merck & Co Inc, AbbVie Inc.
Should I own both XLV and SHSSX?
Owning both adds little diversification: most of their top holdings are the same, so most investors pick one — often the one with the lower expense ratio.
Which holds more stocks, XLV or SHSSX?
SHSSX is broader, with 155 positions versus 65 for XLV. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.